Vivos Therapeutics (VVOS) Assets Average (2021 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Assets Average of $25.1 million for Q1 2026, up 88.94% year-over-year from $13.3 million in Q1 2025, and down 1.18% quarter-over-quarter from $25.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Assets Average (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Assets Average for 6 consecutive years, with $25.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 88.94% year-over-year to $25.1 million; the TTM figure through Mar 2026 stood at $25.1 million (up 88.94% YoY), while the FY2025 annual figure was $20.2 million, up 55.44% from the prior year.
- Assets Average fell to $25.1 million in Q1 2026 per VVOS's latest filing, from $25.4 million in the prior quarter.
- Across five years, Assets Average topped out at $31.6 million in Q1 2022 and bottomed at $10.5 million in Q4 2023.
- Historically, Assets Average has averaged $18.5 million across 5 years, with a median of $15.6 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average sank 57.01% — and 2026, when it jumped 88.94%.
- Vivos Therapeutics' Assets Average stood at $16.1 million in 2022, then plunged by 34.47% to $10.5 million in 2023, then jumped by 45.54% to $15.3 million in 2024, then jumped by 65.83% to $25.4 million in 2025, then declined by 1.18% to $25.1 million in 2026.
- Business Quant data shows VVOS's Assets Average at $25.1 million in Q1 2026, $25.4 million in Q4 2025, and $25.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Vivos Therapeutics | 4.97 Mn | 3.17 Mn | 2.95 Mn | 24.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.10 Mn |
| Dec 31, 2025 | 25.40 Mn |
| Sep 30, 2025 | 25.84 Mn |
| Jun 30, 2025 | 18.66 Mn |
| Mar 31, 2025 | 13.28 Mn |
| Dec 31, 2024 | 15.32 Mn |
| Sep 30, 2024 | 15.59 Mn |
| Jun 30, 2024 | 13.82 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | 10.52 Mn |
| Sep 30, 2023 | 12.03 Mn |
| Jun 30, 2023 | 15.42 Mn |
| Mar 31, 2023 | 15.41 Mn |
| Dec 31, 2022 | 16.06 Mn |
| Sep 30, 2022 | 21.39 Mn |
| Jun 30, 2022 | 26.97 Mn |
| Mar 31, 2022 | 31.62 Mn |
| Dec 31, 2021 | 37.36 Mn |
| Sep 30, 2021 | 43.59 Mn |
| Jun 30, 2021 | 34.06 Mn |